House · Passed · 2025-2026 Regular Session
HB 352: Georgia Gestational Diabetes Management Act; enact
Last action July 1, 2025 · Effective Date
Georgia House Bill 352 expands Medicaid coverage for continuous glucose monitors to include pregnant Medicaid recipients diagnosed with gestational diabetes, not just those on daily insulin or with severe hypoglycemia.
The summaries below were written by an AI model (claude-sonnet-5) from the text of the bill and are not part of it. Quote the text, not the summary. The stored text is the Enrolled version, the latest the General Assembly's website lists.
In plain language
Georgia's Medicaid program already covers continuous glucose monitors for some people with diabetes, but only if they meet certain criteria, such as taking daily insulin or having a history of dangerous low blood sugar episodes. This bill, known as the Georgia Gestational Diabetes Management Act, adds a new qualifying condition: having gestational diabetes, a form of diabetes that develops during pregnancy. The bill amends Georgia's Medicaid statute (O.C.G.A. § 49-4-159.4) so that a Medicaid recipient can qualify for a continuous glucose monitor simply by having gestational diabetes, alongside the existing options of daily insulin use or a documented history of problematic hypoglycemia. It also updates the coverage start date referenced in the law from July 1, 2023 to July 1, 2025. The recipient must still be diagnosed by a treating practitioner and show sufficient training in using the device.
What the bill does
- Adds gestational diabetes as a qualifying condition for Medicaid coverage of continuous glucose monitors, without requiring daily insulin use or a hypoglycemia history.
- Updates the effective date in the Medicaid coverage statute (O.C.G.A. § 49-4-159.4) from July 1, 2023 to July 1, 2025.
- Keeps existing requirements that a treating practitioner diagnose the recipient with diabetes and confirm adequate training in using the monitor.
- Preserves the existing coverage paths for recipients on daily insulin or with a documented history of severe low blood sugar events.
Who it affects
Pregnant Georgians on Medicaid who are diagnosed with gestational diabetes, along with the treating practitioners who diagnose and prescribe for them, and the Georgia Department of Community Health, which administers Medicaid coverage rules for continuous glucose monitors.
Why it matters
Pregnant Medicaid recipients with gestational diabetes who previously did not qualify for coverage of a continuous glucose monitor because they were not on daily insulin or did not have a history of severe hypoglycemia could now get the device covered, potentially helping them track blood sugar during pregnancy.
Key provisions
- Section 1 names the bill the 'Georgia Gestational Diabetes Management Act.'
- Section 2 amends O.C.G.A. § 49-4-159.4(a) to change the coverage start reference from July 1, 2023 to July 1, 2025.
- Section 2 adds 'has gestational diabetes' as a new standalone qualifying criterion alongside daily insulin use and problematic hypoglycemia history.
- Section 2 retains the requirement that a treating practitioner diagnose diabetes mellitus and confirm training in using the monitor before coverage applies.
- Section 3 repeals any conflicting laws.
From the bill
“the department shall include coverage for continuous glucose monitors as a benefit under Medicaid via the most cost-effective benefit delivery channel”
“Has gestational diabetes”
Status timeline
- Effective Date
- Act 260
- House Date Signed by Governor (House)
- House Sent to Governor (House)
- House Agreed Senate Amend or Sub (House)
- Senate Passed/Adopted By Substitute (Senate)
- Senate Third Read (Senate)
- Senate Taken from Table (Senate)
Show full history (18 actions)
- Senate Tabled (Senate)
- Senate Read Second Time (Senate)
- Senate Committee Favorably Reported By Substitute (Senate)
- Senate Read and Referred (Senate)
- House Passed/Adopted By Substitute (House)
- House Third Readers (House)
- House Committee Favorably Reported By Substitute (House)
- House Second Readers (House)
- House First Readers (House)
- House Hopper (House)
Sponsors
- Devan Seabaugh (R, HD-34)
- Sharon Cooper (R, HD-45)
- Danny Mathis (R, HD-133)
- Darlene Taylor (R, HD-173)
- Tremaine Teddy Reese (D, HD-140)
- Carter Barrett (R, HD-24)
- Kay Kirkpatrick (R, SD-32)
Votes
- House voteFebruary 24, 2025
169 yea, 2 nay (2 not voting, 7 excused)
- Senate voteApril 4, 2025
51 yea, 1 nay (1 not voting, 3 excused)
- House voteApril 4, 2025
163 yea, 2 nay (3 not voting, 12 excused)
Topics
- Medicaid coverage
- gestational diabetes
- diabetes management
- maternal health
- continuous glucose monitors